Who founded Corbus Pharmaceuticals?

Corbus Pharmaceuticals was founded by Yuval Cohen in 2013.

Who are Corbus Pharmaceuticals's investors?

Corbus Pharmaceuticals's investors include Boston Harbor Angels.

How much funding has Corbus Pharmaceuticals raised?

Corbus Pharmaceuticals has disclosed $6.4M raised across 3 rounds.

Where is Corbus Pharmaceuticals headquartered?

Corbus Pharmaceuticals is headquartered in New York, US.

Corbus Pharmaceuticals

NASDAQ: CRBP

New York, US · Founded 2013 · 1 known investors

Find your way into Corbus Pharmaceuticals

4 people in our graph share verified history with the Corbus Pharmaceuticals team — schools, employers, funds. One of them is your warm intro.

Reinhardt Kotzéunlockedknows Yuval Cohen · together at Cape Peninsula University of Technology (overlapped)

knows the team · via Corbus Pharmaceuticals

×2knows the team · via Cape Peninsula University of Technology

Corbus Pharmaceuticals is a biopharmaceutical company developing therapies for critical stages of clinical development, with a focus on advancing patient-centered progress in drug development. The company is led by a senior leadership team with expertise in pharmaceutical research, regulatory affairs, and clinical development.

Biotech Healthtech Medical Devices

Founders & leadership

Corbus Pharmaceuticals was founded in 2013 by Yuval Cohen.

Yuval Cohen inChief Executive Officer and DirectorYuval Cohen is Chief Executive Officer and Director of Corbus Pharmaceuticals, a biopharmaceutical company in clinical development. He has background in drug discovery and development, with experience in anti-inflammatory, oncology, and obesity therapeutics.

Board

David HochmanBoard director

John BrancaccioBoard director

Investors · 1

Boston Harbor AngelsBoston · $250K – $1.5M

Reported raises · per SEC filings

Form D private placements

$6.4M disclosed across 3 rounds · 2013–2014

▶$6.3MraisedApr 2014 · 45 investors · Investing

Rule 506(b)

Officers, directors & promoters on the filing

Robert ZurierExecutive Officer
Yuval CohenExecutive Officer, Director
Alan HolmerDirector
Sean MoranExecutive Officer
David HochmanDirector
Mark TepperExecutive Officer

Offering amount: $13M
Amount sold: $6.3M
Sales commissions: $1.3M
Placement agents: Aegis Capital Corp.
First sale: Apr 2014
Incorporated: Corporation, Delaware, 2013
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$19.8KraisedMar 2014 · 3 investors · Investing

Rule 506(b)

Officers, directors & promoters on the filing

John BrancaccioExecutive Officer
David HochmanExecutive Officer, Director

Offering amount: $30K
Amount sold: $19.8K
First sale: Mar 2014
Incorporated: Corporation, Delaware, 2013
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$90KraisedJan 2014 · 19 investors · Investing

Rule 506(b)

Officers, directors & promoters on the filing

David HochmanExecutive Officer, Director
John BrancaccioExecutive Officer

Offering amount: $90K
Amount sold: $90K
First sale: Dec 2013
Incorporated: Corporation, Delaware, 2013
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 7

by search overlap

Seeking Alpha31 shared keywordsSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.

Simply Wall St30 shared keywordsSimply Wall St is an investment platform that provides financial data visualization and analysis tools for individual investors. The platform serves long-term investors globally by simplifying complex market information into visual and narrative formats to make stock investing more accessible.

TipRanks29 shared keywordsFinancial analysis and stock research platform.

StockTwits28 shared keywordsStocktwits operates an online community platform where investors and traders share ideas, analysis, and trade discussions organized around stock tickers. The page presented is its community guidelines rather than a product description.

Public27 shared keywordsPublic is a trading platform that allows users to buy and sell cryptocurrencies including Bitcoin, Ethereum, and memecoins through accounts managed by Zero Hash LLC, a New York State-licensed virtual currency business.

TradingView27 shared keywordsTradingView is a charting platform and social network used by over 100 million traders and investors worldwide to analyze and trade across global financial markets. The platform provides tools for technical analysis, market data, and community collaboration for retail and institutional traders.

Robinhood27 shared keywordsRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.

Companies competing with Corbus Pharmaceuticals for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Corbus Pharmaceuticals do?: Corbus Pharmaceuticals is a biopharmaceutical company developing therapies for critical stages of clinical development, with a focus on advancing patient-centered progress in drug development. The company is led by a senior leadership team with expertise in pharmaceutical research, regulatory affairs, and clinical development.
Who founded Corbus Pharmaceuticals?: Corbus Pharmaceuticals was founded by Yuval Cohen in 2013.
Who are Corbus Pharmaceuticals's investors?: Corbus Pharmaceuticals's investors include Boston Harbor Angels.
How much funding has Corbus Pharmaceuticals raised?: Corbus Pharmaceuticals has disclosed $6.4M raised across 3 rounds.
Where is Corbus Pharmaceuticals headquartered?: Corbus Pharmaceuticals is headquartered in New York, US.